Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
Paul S. Appelbaum, MD
Advertisement
Articles by Paul S. Appelbaum, MD
Advertisement
Latest Updated Articles
- Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask
Published: October 14th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
3
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5
